Page 411 - Read Online

Gonzalez et al. Sunitinib effectiveness and safety in Costa Rica

2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, 16. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM,
Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW,
Cancer Incidence and Mortality Worldwide: IARC CancerBase No. Baum CM, Figlin RA. Sunitinib versus interferon alfa in metastatic
11 [Internet]. Lyon, France: International Agency for Research on renal-cell carcinoma. N Engl J Med 2007;356:115-24.
Cancer; 2013. Available from: http://globocan.iarc.fr. [Accessed on 17. Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S,
16/04/2016] Hariharan S, Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski
3. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman P, Mainwaring P, Nieto A, Yuan J, Bukowski R. Safety and efficacy
A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guillé of sunitinib for metastatic renal-cell carcinoma: an expanded-access
F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, trial. Lancet Oncol 2009;10:757-63.
Belldegrun AS, Pantuck AJ. Prognostic value of histologic subtypes 18. Gore ME, Szczylik C, Porta C, Bracarda S, Bjarnason GA, Oudard S,
in renal cell carcinomas: a multicenter experience. J Clin Oncol Lee SH, Haanen J, Castellano D, Vrdoljak E, Schöffski P, Mainwaring
2005;23:2763-71. P, Hawkins RE, Crinò L, Kim TM, Carteni G, Eberhardt WE, Zhang
4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer K, Fly K, Matczak E, Lechuga MJ, Hariharan S, Bukowski R. Final
J Clin 2012;62:10-29. results from the large sunitinib global expanded-access trial in
5. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, metastatic renal cell carcinoma. Br J Cancer 2015;113:12-9.
Merseburger AS, Patard JJ, Mulders PF, Sinescu IC; European 19. Smaletz O. Current management and future directions in the treatment
Association of Urology Guideline Group. EAU guidelines on renal of advanced renal cell carcinoma - a Latin American perspective: 10
cell carcinoma: the 2010 update. Eur Urol 2010;58:398-406. years in review. Int Braz J Urol 2015;41:835-43.
6. Van PH, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MA, 20. Barrios CH, Herchenhorn D, Chacón M, Cabrera-Galeana P, Sajben
Laguna MP, Marberger M, Montorsi F, Polascik TJ, Ukimura O, Zhu G. P, Zhang K. Safety and efficacy of sunitinib in patients from Latin
Treatment of localised renal cell carcinoma. Eur Urol 2011;60:662-72. America: subanalysis of an expanded access trial in metastatic renal
7. Subotic S, Wyler S, Bachmann A. Surgical treatment of localised renal cell carcinoma. Onco Targets Ther 2016;9:5839-45.
cancer. Eur Urol S 2012;11:60-5. 21. Hutson TE, Bukowski RM, Rini BI, Gore ME, Larkin JM, Figlin RA,
8. Minardi D, Quaresima L, Santoni M, Bianconi M, Scartozzi M, Barrios CH, Escudier B, Lin X, Fly K, Martell B, Matczak E, Motzer
Cascinu S, Muzzonigro G. Recent aspects of sunitinib therapy in RJ. Efficacy and safety of sunitinib in elderly patients with metastatic
patients with metastatic clear-cell renal cell carcinoma: a systematic renal cell carcinoma. Br J Cancer 2014;110:1125-32.
review of the literature. Curr Urol Rep 2015;16:3. 22. Miyake H, Miyazaki A, Harada K, Fujisawa M. Assessment of
9. Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor efficacy, safety and quality of life of 110 patients treated with sunitinib
gene. Nat Rev Cancer 2015;15:55-64. as first-line therapy for metastatic renal cell carcinoma: experience in
10. Fung SMC, Castro JA. Overall survival analysis in metastatic clear real-world clinical practice in Japan. Med Oncol 2014;31:978.
cell renal cell Carcinoma, in the Costa Rican Health Care System. 23. Castellano D, DuhMS, Korves C, Suthoff ED, Neary M, Hernández
(CCSS) Data from 2007 to 2012. Waxapa 2013;9:5-10. Pastor LJ, Bellmunt J. Safety and treatment patterns of angiogenesis
11. Gan HK, Seruga B, Knox JJ. Sunitinib in solid tumors. Expert Opin inhibitors in patients with advanced renal cell carcinoma in Spain.
Investig Drugs 2009;18:821-34. Expert Opin Drug Saf 2013;12:455-63.
12. Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, 24. Ansari J, Fatima A, Fernando K, Collins S, James ND, Porfiri E.
Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Sunitinib in patients with metastatic renal cell carcinoma: Birmingham
Bacik J, Kim ST, Baum CM, Michaelson MD. Sunitinib in patients experience. Oncol Rep 2010;24:507-10.
with metastatic renal cell carcinoma. JAMA 2006;295:2516-24. 25. Vrdoljak E, Géczi L, Mardiak J, Ciuleanu TE, Leyman S, Zhang K,
13. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Sajben P, Torday L. Central and Eastern European experience with
Oudard S, Negrier S, Szczylik C, Pili R, Bjarnason GA, Garcia-del- sunitinib in metastatic renal cell carcinoma: a sub-analysis of the
Muro X, Sosman JA, Solska E, Wilding G, Thompson JA, Kim ST, global expanded-access trial. Pathol Oncol Res 2015;21:775-82.
Chen I, Huang X, Figlin RA. Overall survival and updated results for 26. Abdel-Rahman O, Fouad M. Efficacy and toxicity of sunitinib for
sunitinib compared with interferon alfa in patients with metastatic non clear cell renal cell carcinoma (RCC): a systematic review of the
renal cell carcinoma. J Clin Oncol 2009;27:3584-90. literature. Cri Rev Oncol Hemat 2015;94:238-50.
14. National Comprehensive Cancer Network (NCCN ver 2.2016), 27. Lee JL, Ahn JH, Lim HY, Park SH, Lee SH, Kim TM, Lee DH, Cho
Kidney Cancer, https://www.nccn.org/professionals/physician_gls/ YM, Song C, Hong JH, Kim CS, Ahn H. Multicenter phase II study
pdf/kidney.pdf. [Accessed on 09/05/2016] of sunitinib in patients with non-clear cell renal cell carcinoma. Ann
15. Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo Oncol 2012;23:2108-14.
V, Eisen T, Horwich A; ESMO Guidelines Working Group. Renal 28. Shi HZ, Tian J, Li CL. Safety and efficacy of sunitinib for advanced
cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, non-clear cell renal cell carcinoma. Asia Pac J Clin Oncol
treatment and follow-up. Ann Oncol 2014;25 Suppl 3:iii49-56. 2015;11:328-33.

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ October 21, 2016 401